Trial intelligence / Profile preview

Letrozole vs Placebo after 5 years of AI in breast cancer

NCT00754845Phase 3Completed

Sponsor
Canadian Cancer Trials Group
Start
Nov 2004
Primary completion
Dec 2015
Modality
Orthosteric Ligands
Countries
2
01

Overview

A Phase 3 trial of letrozole in breast cancer, sponsored by Canadian Cancer Trials Group. Started Nov 2004; status: completed.

02

Drugs

letrozole
03

Conditions

breast cancer

Beyond the preview

Go deeper on NCT00754845.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00754845.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call